Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04988451 · ClinicalTrials.gov registry record · NA
Family ASL: Longitudinal Study of Deaf Children and Hearing Parents Who Receive Services to Support the Learning of ASL
A NA study of Hearing Loss and Deafness, sponsored by University of Connecticut.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04988451: Active NA study of Hearing Loss and Deafness, sponsored by University of Connecticut.
NCT04988451 is a NA study of Hearing Loss and Deafness that is active but no longer recruiting, run by University of Connecticut. The registered enrollment target is 40 participants, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04988451, a NA study of Hearing Loss and Deafness, is active but no longer recruiting, sponsored by University of Connecticut.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the development of American Sign Language by deaf and hard of hearing (DHH) children and their parents.
Primary Outcome
Participants copy ASL signs produced on video; their productions are scored for phonological accuracy and reported as percent correct out of all possible phonological features. Weekly measures are taken for SCD analysis.
Conditions Studied
Interventions
- BEHAVIORAL ASL Services
Study Locations (1)
Connecticut
- University of Connecticut - Department of Linguistics - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2025-11-30 |
| Phase | NA |
What the registry record for NCT04988451 still lists
NCT04988451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which ASL Services is the first listed.
NCT04988451 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04988451 about?
NCT04988451 is a clinical study titled "Family ASL: Longitudinal Study of Deaf Children and Hearing Parents Who Receive Services to Support the Learning of ASL". This study examines the development of American Sign Language by deaf and hard of hearing (DHH) children and their parents.
What is the current status of trial NCT04988451?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-07-20. Estimated completion is 2025-11-30.
What conditions does trial NCT04988451 study?
This clinical trial studies the following conditions: Hearing Loss, Deafness.
What interventions are being tested in trial NCT04988451?
The interventions under investigation include: ASL Services (BEHAVIORAL).
Who is sponsoring clinical trial NCT04988451?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04988451 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04988451's enrollment target sits among peer trials
40 45th of 58 higher than 12 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI